Viewing Study NCT00248820



Ignite Creation Date: 2024-05-05 @ 12:06 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00248820
Status: UNKNOWN
Last Update Posted: 2007-11-22
First Post: 2005-11-02

Brief Title: Contrast-Enhanced Ultrasound Ability in the Characterization of Ovarian Masses
Sponsor: University Hospital Tours
Organization: University Hospital Tours

Study Overview

Official Title: Contrast-Enhanced Ultrasound Ability in the Characterization of Ovarian Masses
Status: UNKNOWN
Status Verified Date: 2007-11
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study intends to assess the ability of contrast-enhanced ultrasound in the detection of benign and malignant ovarian masses compared to unenhanced ultrasound

By using an intravascular contrast agent this noninvasive and feasible imaging technique will allow the investigators to define specific microcirculation patterns in 100 women with ovarian lesions

The intravascular contrast agent properties will be compared between benign and malignant adnexal masses

The final purpose of this ultrasonography is to allow the early detection of tumors and to improve the characterization between benign and malignant lesions
Detailed Description: SonoVue Sulphur hexafluoride microbubbles is a microbubbles preparation that is stable resistant to pressure and specifically designed to be used as a contrast agent for ultrasound imaging

Study design one contrast-enhanced ultrasonography is proposed before any surgery to patients with ovarian mass

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None